tiprankstipranks
Trending News
More News >
Jefferson Capital, Inc. (JCAP)
NASDAQ:JCAP
US Market

Jefferson Capital, Inc. (JCAP) AI Stock Analysis

Compare
21 Followers

Top Page

JCAP

Jefferson Capital, Inc.

(NASDAQ:JCAP)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
$21.00
▲(3.60% Upside)
Action:ReiteratedDate:03/15/26
The score is driven primarily by mixed fundamentals: strong profitability is outweighed by a major 2025 cash flow breakdown and high leverage. Technicals add near-term caution (below key moving averages with negative MACD), while very low valuation and a constructive earnings-call outlook provide meaningful support.
Positive Factors
Revenue & Profitability Growth
Sustained top-line expansion and high net margins indicate durable earnings power from the core collections/deployments model. Multi-year revenue growth coupled with a ~30.6% net margin supports long-term cash generation potential and resilience in the company’s operating economics.
Sector-leading Cash Efficiency
Above-peer cash efficiency reflects structurally lower cost-to-collect and operational scale in servicing portfolios. Higher efficiency supports sustainable margins and allows more flexible deployment of capital into purchases, underwriting, and shareholder returns over the medium term.
Improved Liquidity & Capital Flexibility
A larger, extended revolver and sub-2.0x leverage target materially reduce near-term refinancing risk and permit funding of portfolio purchases. This structural improvement in liquidity increases strategic optionality for deployments, bond repayments, and targeted share returns over coming quarters.
Negative Factors
Free Cash Flow Collapse
A near-total collapse of free cash flow is a durable red flag for earnings quality and liquidity conversion. If driven by collection or working-capital changes rather than one-offs, it constrains capacity to fund deployments, meet debt service, sustain dividends, and increases reliance on external funding.
High and Rising Leverage
Material debt growth and substantially higher leverage amplify downside risk and reduce balance-sheet flexibility. In a capital-intensive credit services model, elevated leverage increases sensitivity to funding costs and market access, especially problematic if cash conversion remains impaired.
Seasonality & ERC Replacement Pressure
Large near-term ERC runoff requires meaningful asset purchases to sustain revenue run-rate. Structural reliance on timely, accretive deployments creates execution risk: failure to replace runoff at attractive multiples can compress future NOI and strain margins amid elevated legal costs and macro headwinds.

Jefferson Capital, Inc. (JCAP) vs. SPDR S&P 500 ETF (SPY)

Jefferson Capital, Inc. Business Overview & Revenue Model

Company DescriptionJefferson Capital, Inc. provides debt recovery solutions and other related services in the United States, the United Kingdom, Canada, and Latin America. The company primarily purchases portfolios of previously charged-off consumer receivables at deep discounts to face value and manage them by working with individuals as they repay their obligations and work toward financial recovery. It offers consumer receivables, including credit card, secured and unsecured automotive, telecom and utilities, and other receivables. The company also provides debt servicing and other portfolio management services to credit originators for nonperforming loans. Jefferson Capital, Inc. was founded in 2002 and is headquartered in Sartell, Minnesota.

Jefferson Capital, Inc. Earnings Call Summary

Earnings Call Date:Mar 12, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Aug 13, 2026
Earnings Call Sentiment Positive
The call presented strong operational and financial momentum with record collections, deployments, revenue, improved leverage, and successful integration of strategic portfolio purchases (Conn's and Bluestem). Efficiency and underwriting strength were reiterated, and capital structure improvements and shareholder returns were highlighted. Key challenges include materially higher upfront legal/court costs driven by increased legal volumes, seasonality and the need to replace ERC runoff, and macro vulnerabilities tied to lower consumer savings and rising insolvencies. Overall, positive business fundamentals and growth track record outweigh manageable near-term cost and seasonality pressures.
Q4-2025 Updates
Positive Updates
Record Collections and Strong YoY Growth
Generated record collections of $245 million in Q4, up 41% year-over-year, driven by deployments in 2023–2024 and portfolio contributions (Conn's contributed $36M and Bluestem $14M in the quarter).
Record Deployments and Growing ERC
Record deployments of $381 million in Q4, up 6% year-over-year; estimated remaining collections (ERC) reached a record $3.4 billion, up 23% year-over-year, with 58% expected to be collected through 2027 and $1.1 billion expected in the next 12 months.
Revenue and Profitability Improvements
Quarterly revenue was a record $155 million, up 30% year-over-year; adjusted EPS of $0.69; adjusted pretax income of $51 million (up 15% YoY) and adjusted cash EBITDA of $178 million (up 34% YoY).
Sector-Leading Operating Efficiency
Delivered a sector-leading cash efficiency ratio of 71% in Q4 (71% aided by Conn's/Bluestem; 68% excluding those portfolios). Full-year 2025 cash efficiency was 74% (69.7% excluding Conn's/Bluestem), reflecting sustained cost-to-collect advantages.
Strong Capital Structure and Liquidity
Amended revolver increased committed capital by $175 million to $1.0 billion, extended tenor, improved pricing (~50 bps) and effective interest savings (~60 bps); net debt to adjusted cash EBITDA improved to 1.9x, below peers; facility had $232M drawn and $300M capacity earmarked for May 2026 bond repayment (bonds pre-funded via $500M unsecured issuance).
Successful Strategic Transactions and Integration
Completed Bluestem acquisition (closed Dec 4) and Conn's portfolio purchase; both integrated with performance in line with expectations and contributed meaningful revenue/NOI (Conn's: $15.5M portfolio revenue, $1.3M servicing revenue, $10.7M NOI; Bluestem: $5.4M revenue, $2.5M NOI).
Capital Allocation and Shareholder Returns
Conducted a follow-on equity offering improving float and reducing J.C. Flowers ownership to 53%; repurchased ~3 million shares (~5%) for $59M as a tactical move; Board declared a regular quarterly dividend of $0.24/share (≈4.7% annualized yield as of February).
Long-Term Growth Track Record
From 2019 through 2025 Jefferson Capital delivered strong multi-year growth: revenue CAGR 27%, net operating income CAGR 37%, and net income CAGR 43%, highlighting sustained profitability and growth through cycles.
Negative Updates
Rising Legal Channel and Court Costs
Court costs rose to $17.7 million in Q4, an 86% increase year-over-year, driven by higher legal channel volumes; these are upfront expenses and management expects core court costs to remain at elevated levels given larger inventory of suit-eligible accounts.
Increased Operating Expenses
Operating expenses for Q4 were $84 million, up 30% year-over-year (versus collections growth of 41%), reflecting higher legal and scale-related costs associated with accelerated deployment and processing volumes.
Seasonality and Rolloff Replacement Need
Business is highly seasonal (Q4 peak for deployments); company expects ~$1.1B ERC to run off in next 12 months and estimates needing ~ $582M of deployments (based on 2025 purchase multiples) to replace that runoff while only $225M was contracted via forward flows as of Dec 31, implying potential near-term replacement pressure.
Underlying Efficiency Below Headline Without Performing Portfolios
Headline efficiency benefited from lower-cost collections from Conn's and Bluestem; excluding those, Q4 cash efficiency would have been 68% (FY 69.7%), lower than headline metrics and indicating dependence on certain performing/low-cost portfolios for peak efficiency.
Macroeconomic Vulnerabilities and Consumer Strain
Management noted consumer savings at $831 billion versus a 2013–2019 prepandemic average of $1.1 trillion (inflation-adjusted), and rising insolvencies—factors that increase supply but also signal consumer vulnerability and potential credit deterioration risks.
Limited Near-Term Pricing Improvement in Some Asset Classes
Management reported little change in pricing for certain asset classes (e.g., prime credit cards), indicating limited near-term upside from improved purchase multiples in those markets despite modest supply increases.
Company Guidance
Management's guidance emphasized Bluestem as a meaningful contributor in 2026 and reiterated strong near‑term liquidity and deployment targets: they expect to collect $1.1 billion of the $3.4 billion estimated remaining collections (ERC) over the next 12 months (58% of ERC expected through 2027), would need to deploy ~$582 million globally to replace that 12‑month runoff based on 2025 purchase multiples, and already have roughly $225–$274 million of forward‑flow/contracted deployments as of December 31; they flagged seasonality (Q4 is largest for deployments, Q1 typically decelerates) and said legal‑channel costs will remain elevated as suit volumes grow. Capital and tax guidance included a year‑end net debt/adjusted cash EBITDA of 1.9x with a long‑run target of 2.0–2.5x, a $1.0 billion revolver (up $175M) with $232M drawn and $300M capacity earmarked to repay May 2026 bonds (which they may keep to retain a 6% coupon), a $0.24 quarterly dividend (~4.7% annualized yield), a tactical $59M repurchase of 3M shares, and an indicative 2026 tax rate of ~24.5%; efficiency expectations were for underlying cash efficiency in the high‑60s (Q4 cash efficiency 71% including Conn's/Bluestem, 68% excl.; full‑year 2025 74% incl., 69.7% excl.).

Jefferson Capital, Inc. Financial Statement Overview

Summary
Strong reported profitability and revenue growth support the score, but it is heavily offset by a severe 2025 cash flow deterioration (free cash flow collapsing to near zero) and elevated/rising leverage (debt-to-equity up to ~3.60), which increases funding and liquidity risk.
Income Statement
78
Positive
JCAP shows strong profitability for a credit services business, with high margins and solid earnings power. Revenue expanded meaningfully from 2023 to 2025 (from $323M to $613M), and 2025 maintained healthy growth (+6.2%). Profitability is a clear strength: 2025 net margin was ~30.6% and operating profit margin was ~52.9%, both improved versus 2024. A key watch-out is volatility in reported operating performance versus prior years (e.g., shifts in margins), which can occur in this industry depending on portfolio mix, collections, and funding costs.
Balance Sheet
58
Neutral
The balance sheet is the main mixed area: leverage is high and rising, with debt-to-equity increasing from ~2.81 (2023) to ~3.60 (2025). Total debt grew substantially over the period ($771M to $1.71B), increasing financial risk and sensitivity to credit conditions and funding markets. Offsetting this, profitability on equity is strong (ROE ~39% in 2025), indicating the company is generating significant earnings relative to its equity base, but that strength is partly amplified by leverage.
Cash Flow
22
Negative
Cash flow quality weakened sharply in 2025. Operating cash flow and free cash flow collapsed to ~$0.3M versus $168M/$162M in 2024, a ~99.9% decline in free cash flow, which is a major red flag for liquidity and earnings conversion. While prior years (2023–2024) showed strong cash generation and free cash flow closely tracking net income, the 2025 step-down suggests either a one-off working-capital/portfolio cash timing impact or a deterioration in cash collection dynamics—either way it materially increases uncertainty.
BreakdownDec 2025Dec 2024Dec 2023Dec 2019Dec 2018
Income Statement
Total Revenue613.29M433.30M323.07M45.09M31.21M
Gross Profit415.58M308.40M238.44M41.10M29.50M
EBITDA329.47M158.06M121.22M59.17M60.01M
Net Income187.97M105.30M111.52M44.41M54.37M
Balance Sheet
Total Assets2.09B1.65B1.12B812.78M590.41M
Cash, Cash Equivalents and Short-Term Investments47.55M35.51M14.37M3.28M8.71M
Total Debt1.71B1.19B770.93M202.79M24.61M
Total Liabilities1.61B1.27B811.78M223.90M42.54M
Stockholders Equity476.13M382.53M274.79M588.87M547.86M
Cash Flow
Free Cash Flow295.10K162.00M118.99M-180.21M-281.29M
Operating Cash Flow295.10K168.21M120.22M-13.63M-6.30M
Investing Cash Flow0.00-542.37M-403.41M-321.31M-241.75M
Financing Cash Flow0.00388.82M289.86M-4.17M34.97M

Jefferson Capital, Inc. Risk Analysis

Jefferson Capital, Inc. disclosed 78 risk factors in its most recent earnings report. Jefferson Capital, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Jefferson Capital, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$307.61M2.9112.66%10.37%10.48%-30.67%
71
Outperform
$1.57B0.7417.81%5.20%9.32%29.40%
68
Neutral
$5.91B10.2523.40%6.07%9.51%29.38%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
61
Neutral
$1.12B3.5741.10%2.11%
53
Neutral
$675.63M-2.27-27.34%13.89%-899.50%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JCAP
Jefferson Capital, Inc.
20.27
1.72
9.27%
PRAA
Pra Group
17.57
-2.12
-10.77%
OMF
OneMain Holdings
50.42
5.61
12.52%
YRD
Yiren Digital
3.56
-4.00
-52.91%
FINV
FinVolution Group
6.18
-4.18
-40.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 15, 2026